REVUFORJ
Live / Applied — Fourth extension granted (statement of use) (as of 27 Jan 2026)
What this means for you
Not registered yet, but its 19 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97760175
- Mark type
- Stylized text
- Filed
- 19 Jan 2023
- Published for opposition
- 28 Nov 2023
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment
- Class 044 — Medical, beauty and agricultural services: Providing information in the field of cancer treatment; providing links to the web sites of others featuring information about the diagnosis and treatment of cancer
Owner
- Syndax Pharmaceuticals, Inc., Waltham, MA, US
- Syndax Pharmaceuticals, Inc., Waltham, MA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2026 — SOU EXTENSION 4 GRANTED
- 21 Jan 2026 — SOU EXTENSION 4 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2025 — SOU EXTENSION 3 GRANTED
- 21 Jul 2025 — SOU EXTENSION 3 FILED
- 22 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 19 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 May 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 21 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 15 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Apr 2025 — CORRECTED NOA E-MAILED